NeuroPace Inc (Nasdaq:NPCE)

Health Care/Life Sciences • Medical Equipment/Supplies

CIK 1528287

Company

NeuroPace, Inc. develops, manufactures, and markets implantable devices for treating epilepsy and neurological disorders. It offers implantable components, which include the RNS neurostimulator as well as depth and cortical strip leads. The firm's RNS System is designed for the treatment of medically refractory partial epilepsy and includes implantable and external products. The company was founded by Rebecca L. Kuhn, Frank M. Fischer on November 19, 1997 and is headquartered in Mountain View, CA.

Address
455 North Bernardo Avenue
Mountain View, California 94043

Employees
167

Stock Info

Close
$14.20

Day Range
13.60 - 14.85

52 Week Range
3.18 - 18.15

Average volume
79.31K

Short Interest
62.72K (02/15/24)

% of Float Shorted
0.58%

Market Cap
$364.55M

Revenue
$45.52M

Net Income
-$47.08M

2020 Sales Growth
N/A

Rev. per Employee
$360.47K

P/E Ratio
N/A

EPS
-$1.50

Yield
N/A

Dividend
N/A

Ex-Dividend Date
N/A

Key Executives

Board Of Directors

Chairman
Frank M Fischer

Chief Executive Officer & Director
Joel D Becker MBA

Independent Director
Lisa M Andrade MBA

Independent Director
Joseph S Lacob MBA

Independent Director
Renee Compton Ryan MBA

Independent Director
Uri Geiger PhD

Independent Director
Rakhi Kumar MBA

SEC filings

Date	Form	Event
14 Nov, 2024	SC 13G/A
14 Nov, 2024	SC 13G/A
12 Nov, 2024	8-K
12 Nov, 2024	10-Q
4 Nov, 2024	SCHEDULE 1
28 Oct, 2024	4
28 Oct, 2024	144
24 Oct, 2024	4
22 Oct, 2024	4
18 Oct, 2024	4
3 Oct, 2024	4
3 Oct, 2024	SC 13G/A
3 Oct, 2024	144
13 Aug, 2024	10-Q
13 Aug, 2024	8-K
11 Jun, 2024	4
11 Jun, 2024	4
11 Jun, 2024	4
11 Jun, 2024	4
11 Jun, 2024	4
11 Jun, 2024	4
10 Jun, 2024	8-K
8 May, 2024	10-Q
8 May, 2024	8-K
3 May, 2024	4
26 Apr, 2024	4
23 Apr, 2024	4
22 Apr, 2024	ARS
22 Apr, 2024	DEFA14A
22 Apr, 2024	DEF 14A
18 Apr, 2024	4
15 Apr, 2024	4
15 Mar, 2024	144
5 Mar, 2024	8-K
5 Mar, 2024	10-K
5 Mar, 2024	S-8
28 Feb, 2024	4
28 Feb, 2024	4
28 Feb, 2024	4
14 Feb, 2024	SC 13G/A
14 Feb, 2024	SC 13G/A
9 Feb, 2024	SC 13G/A
9 Feb, 2024	SC 13G/A
7 Feb, 2024	8-K
6 Feb, 2024	4
2 Feb, 2024	SC 13G/A
1 Feb, 2024	4
26 Jan, 2024	4
8 Jan, 2024	8-K
28 Dec, 2023	4
22 Dec, 2023	4
20 Dec, 2023	144
7 Dec, 2023	4
6 Dec, 2023	144
4 Dec, 2023	8-K
1 Dec, 2023	4
29 Nov, 2023	144
29 Nov, 2023	4
6 Nov, 2023	8-K
6 Nov, 2023	10-Q
4 Oct, 2023	4
2 Oct, 2023	144
8 Aug, 2023	S-8
8 Aug, 2023	10-Q
8 Aug, 2023	8-K
19 Jul, 2023	4
19 Jul, 2023	3
19 Jul, 2023	8-K
28 Jun, 2023	8-K	CEO Change
14 Jun, 2023	4
14 Jun, 2023	4
14 Jun, 2023	4
14 Jun, 2023	4
14 Jun, 2023	4
14 Jun, 2023	4
12 Jun, 2023	8-K
4 May, 2023	10-Q
4 May, 2023	8-K
25 Apr, 2023	DEFA14A
25 Apr, 2023	DEF 14A
25 Apr, 2023	ARS
13 Apr, 2023	8-K
2 Mar, 2023	10-K
2 Mar, 2023	8-K
2 Mar, 2023	S-8
22 Feb, 2023	4
22 Feb, 2023	4
22 Feb, 2023	4
22 Feb, 2023	4
14 Feb, 2023	SC 13G/A
14 Feb, 2023	SC 13G/A
10 Feb, 2023	SC 13G
9 Feb, 2023	SC 13G
9 Jan, 2023	3
9 Jan, 2023	4
9 Jan, 2023	8-K
23 Nov, 2022	4
23 Nov, 2022	SC 13D/A
22 Nov, 2022	EFFECT
21 Nov, 2022	SC 13D
8 Nov, 2022	8-K
8 Nov, 2022	10-Q
8 Nov, 2022	S-3
2 Nov, 2022	4
20 Oct, 2022	4
11 Oct, 2022	4
7 Oct, 2022	SC 13G
11 Aug, 2022	8-K
11 Aug, 2022	10-Q
21 Jun, 2022	4
21 Jun, 2022	4
21 Jun, 2022	4
21 Jun, 2022	4
21 Jun, 2022	4
21 Jun, 2022	4
17 Jun, 2022	8-K
9 Jun, 2022	4
12 May, 2022	10-Q
12 May, 2022	8-K
22 Apr, 2022	DEF 14A
22 Apr, 2022	DEFA14A
11 Mar, 2022	S-8
10 Mar, 2022	10-K
10 Mar, 2022	8-K
8 Mar, 2022	4
7 Mar, 2022	4
7 Mar, 2022	4
7 Mar, 2022	4
1 Mar, 2022	4
11 Feb, 2022	SC 13G/A
10 Feb, 2022	SC 13G/A
13 Jan, 2022	SC 13G
11 Jan, 2022	8-K
10 Nov, 2021	8-K
10 Nov, 2021	10-Q
2 Nov, 2021	3
2 Nov, 2021	4
1 Nov, 2021	SC 13G
19 Oct, 2021	8-K
8 Oct, 2021	4
8 Oct, 2021	4
8 Oct, 2021	4
8 Oct, 2021	4
9 Sep, 2021	8-K
12 Aug, 2021	10-Q
12 Aug, 2021	8-K
29 Jun, 2021	4/A
29 Jun, 2021	4/A
29 Jun, 2021	4/A
29 Jun, 2021	4/A
8 Jun, 2021	4
8 Jun, 2021	4
8 Jun, 2021	4
8 Jun, 2021	4
3 Jun, 2021	10-Q
3 Jun, 2021	8-K
3 May, 2021	SC 13G
29 Apr, 2021	SC 13G
26 Apr, 2021	4
26 Apr, 2021	4
26 Apr, 2021	8-K
26 Apr, 2021	4
26 Apr, 2021	4
26 Apr, 2021	4
26 Apr, 2021	4
26 Apr, 2021	4
26 Apr, 2021	4
23 Apr, 2021	4
23 Apr, 2021	4
23 Apr, 2021	4
23 Apr, 2021	424B4	IPO completed
23 Apr, 2021	S-8
23 Apr, 2021	4
23 Apr, 2021	4
23 Apr, 2021	4
21 Apr, 2021	EFFECT
21 Apr, 2021	POS AM
21 Apr, 2021	FWP
21 Apr, 2021	CORRESP
21 Apr, 2021	CORRESP
21 Apr, 2021	S-1MEF
20 Apr, 2021	3
20 Apr, 2021	3
20 Apr, 2021	3
20 Apr, 2021	3
20 Apr, 2021	3
20 Apr, 2021	3
20 Apr, 2021	3
20 Apr, 2021	3
20 Apr, 2021	3
20 Apr, 2021	3
20 Apr, 2021	CERT
20 Apr, 2021	EFFECT
20 Apr, 2021	3
20 Apr, 2021	3
20 Apr, 2021	3
16 Apr, 2021	CORRESP
16 Apr, 2021	CORRESP
14 Apr, 2021	S-1/A
14 Apr, 2021	8-A12B
9 Apr, 2021	CORRESP
7 Apr, 2021	UPLOAD
6 Apr, 2021	CORRESP
24 Mar, 2021	S-1
24 Mar, 2021	CORRESP
25 Feb, 2021	UPLOAD
29 Jan, 2021	DRS

Last update:2024-03-06 13:33:59.890531

Sign Up to Subscribe

Interested in special situations?

Join Tickerverse

customize event filters
create watchlists, bookmarks
get email notifications for the latest special situations
browse and analyze public companies, executives and SEC filings

Tickerverse is a great way to find investment opportunities in corporate actions.

By signing up you agree to our Terms of Service and Privacy Policy.